CD44v3, 8‐10 is essential for Slug‐dependent vimentin gene expression to acquire TGF‐β1‐induced tumor cell motility. Issue 8 (8th June 2022)
- Record Type:
- Journal Article
- Title:
- CD44v3, 8‐10 is essential for Slug‐dependent vimentin gene expression to acquire TGF‐β1‐induced tumor cell motility. Issue 8 (8th June 2022)
- Main Title:
- CD44v3, 8‐10 is essential for Slug‐dependent vimentin gene expression to acquire TGF‐β1‐induced tumor cell motility
- Authors:
- Qiu, Shichao
Iimori, Makoto
Edahiro, Keitaro
Fujimoto, Yoshiaki
Matsuoka, Kazuaki
Oki, Eiji
Maehara, Yoshihiko
Mori, Masaki
Kitao, Hiroyuki - Abstract:
- Abstract: CD44 is a widely expressed polymorphic adhesion molecule that has pleiotropic functions in development and tumor progression. Its mRNA undergoes alternative splicing to generate multiple variant (CD44v) isoforms, although the function of each CD44v isoform is not fully elucidated. Here, we show that CD44v plays an important role in the induction of vimentin expression upon transforming growth factor‐β1 (TGF‐β1)‐induced epithelial–mesenchymal transition (EMT). Among multiple CD44v isoforms expressed in NUGC3 gastric cancer cells, CD44v8‐10 and CD44v3, 8‐10 are involved in the acquisition of migratory and invasive properties associated with TGF‐β1‐induced EMT, and only CD44v3, 8‐10 induces the transcription of vimentin mediated by the EMT transcription factor Slug. In primary tumor specimens obtained from patients with gastric cancer, CD44‐containing variant exon 9 (CD44v9) expression and EMT features [E‐cadherin(−)vimentin(+)] were significantly correlated, and EMT features in the cells expressing CD44v9 were associated with tumor invasion depth, lymph node metastasis, and pStage, which indicate invasive and metastatic properties, and poor prognosis. These results indicate that certain CD44v isoforms promote tumor cell motility and metastasis in gastric cancer in association with EMT features, and CD44v3, 8‐10 may contribute to these clinical characteristics. Abstract : In this study, we show that CD44v3, 8‐10 and CD44v8‐10 are involved in the acquisition ofAbstract: CD44 is a widely expressed polymorphic adhesion molecule that has pleiotropic functions in development and tumor progression. Its mRNA undergoes alternative splicing to generate multiple variant (CD44v) isoforms, although the function of each CD44v isoform is not fully elucidated. Here, we show that CD44v plays an important role in the induction of vimentin expression upon transforming growth factor‐β1 (TGF‐β1)‐induced epithelial–mesenchymal transition (EMT). Among multiple CD44v isoforms expressed in NUGC3 gastric cancer cells, CD44v8‐10 and CD44v3, 8‐10 are involved in the acquisition of migratory and invasive properties associated with TGF‐β1‐induced EMT, and only CD44v3, 8‐10 induces the transcription of vimentin mediated by the EMT transcription factor Slug. In primary tumor specimens obtained from patients with gastric cancer, CD44‐containing variant exon 9 (CD44v9) expression and EMT features [E‐cadherin(−)vimentin(+)] were significantly correlated, and EMT features in the cells expressing CD44v9 were associated with tumor invasion depth, lymph node metastasis, and pStage, which indicate invasive and metastatic properties, and poor prognosis. These results indicate that certain CD44v isoforms promote tumor cell motility and metastasis in gastric cancer in association with EMT features, and CD44v3, 8‐10 may contribute to these clinical characteristics. Abstract : In this study, we show that CD44v3, 8‐10 and CD44v8‐10 are involved in the acquisition of migratory and invasive properties associated with TGF‐β1‐induced EMT, and only CD44v3, 8‐10 induces the transcription of vimentin mediated by the EMT transcription factor Slug. Clinically, tumors with the combination of CD44v9 expression and EMT features were significantly associated with tumor invasive and metastatic activities. Therefore, targeting CD44v may be a promising therapeutic strategy to prevent tumor progression at the early stage of gastric cancer. … (more)
- Is Part Of:
- Cancer science. Volume 113:Issue 8(2022)
- Journal:
- Cancer science
- Issue:
- Volume 113:Issue 8(2022)
- Issue Display:
- Volume 113, Issue 8 (2022)
- Year:
- 2022
- Volume:
- 113
- Issue:
- 8
- Issue Sort Value:
- 2022-0113-0008-0000
- Page Start:
- 2654
- Page End:
- 2667
- Publication Date:
- 2022-06-08
- Subjects:
- CD44v3, 8‐10 -- epithelial–mesenchymal transition -- slug -- TGF‐β1 -- vimentin
Cancer -- Periodicals
Neoplasms -- Periodicals
Research -- Periodicals
Electronic journals
616.994005 - Journal URLs:
- http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/journal=1347-9032;screen=info;ECOIP ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1349-7006 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/cas.15353 ↗
- Languages:
- English
- ISSNs:
- 1347-9032
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3046.603000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 23007.xml